enVVeno Medical Corporation (5HJ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

3.1000

+0.0200

(+0.65%)

As of 08:10AM CET. Market open.

Loading interactive chart...

ACCESSWIRE
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
Definitive One Year Data from PMA Application to be Presented Wednesday at 51st Annual VEITH Symposium Company to Host a Conference Call with the PIs Presenting the Pivotal Trial Data on Wednesday, November 20th at 2:00 PM Eastern Time - Click Here ...
ACCESSWIRE
enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
Continued progress toward submission of 5th and final module of FDA premarket approval (PMA) application for VenoValve® in Q4 GLP study for enVVe® transcatheter-based replacement venous valve underway; On track to file IDE approval for pivotal trial ...